Study types
- article 8
Condition tags
- endometriosis 5
- dysmenorrhea 1
- infertility 1
Top journals
Frequent coauthors
- R B Greenblatt 5
- Bohler Cs 1
- D W Bruneteau 1
- Barfield We 1
- C S Bohler 1
- Colle Ml 1
- Bruneteau Dw 1
- D R Mishell 1
- Dawood My 1
- Aksu Mf 1
The efficacy of therapeutic doses of Provest (10 mg medroxyprogesterone acetate .05 mg ethinyl estradiol) in controlling adolescent menstrual disorders was evaluated in 19 girls. Treatment for 3-6 months satisfactorily prevented amenorrhea-…
One hundred thirty-five women with benign breast disease (BBD) were treated with danazol, an impeded androgen. Their ages ranged from 19 to 60 years (mean age, 30). The dose varied from 100 to 800 mg per day for 90 to 180 days, depending up…
The contraceptive properties of Danazol a steroid derivative of eth isterone were investigated in 30 volunteers. The drug was administered for 90 days in daily doses of either 50 100 or 200 mg. There were no pregnancies. Consistent inhibiti…
Danazol (2-3-isoxazol-17alpha-ethinyl-testosterone) was prescribed to 42 normally cycling women some endometriosis patients some primary and secondary infertility patients 6 girls with precocious puberty several women with breast disorders …
The past present and future of the oral contraceptive pill is summarized broadly including ancient history and efficacy of traditional contraceptives and use of early estrogen treatment for dysmennorhea (1940-1952). The present development …